CHI3L1 and obstructive sleep apnea syndrome: A meta-analysis by Zhang et al. included five studies of varying quality, with patients from different demographic backgrounds and different baseline characteristics, and concluded that OSA patients present elevated serum YKL-40 concentrations, which may serve as a potential biomarker for diagnosis and screening of OSA.